Tianjin Ringpu Bio-Technology Co.,Ltd.

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
15.9 ^CNY	0.00%		-0.13%	-2.99%

10:47am	Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023	CI

Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Dividend for Year 2021

March 28, 2022 at 03:44 pm EDT

Tianjin Ringpu Bio-Technology Co.,Ltd. proposed Cash dividend/10 shares (tax included) of CNY 3.50000000 for year 2021.

Latest news about Tianjin Ringpu Bio-Technology Co.,Ltd.

Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04:47am	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023	Apr. 01	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.	Mar. 29	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.	Jan. 26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.	Jan. 24	CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.	Jan. 02	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.	23-10-26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.	23-10-25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs	23-06-26	MT
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement	23-06-26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023	23-06-02	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022	23-04-24	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022	23-04-02	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.	23-03-20	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments	22-09-14	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Cash Dividend of A Shares for 2021, Payable on 13 June 2022	22-06-07	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for the Year 2021	22-04-19	CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Dividend for Year 2021	22-03-28	CI

Chart Tianjin Ringpu Bio-Technology Co.,Ltd.

Duration

Period

Chart Tianjin Ringpu Bio-Technology Co.,Ltd.

More charts

TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Sector

Pharmaceuticals

Calendar

2024-04-25 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Tianjin Ringpu Bio-Technology Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

15.9 CNY

Average target price

20.97 CNY

Spread / Average Target

+31.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-2.99%	1.02B
ZOETIS INC.	-22.30%	68.94B
BLUESTAR ADISSEO COMPANY	+18.88%	3.43B
VIRBAC	-3.62%	3.22B
VIMIAN GROUP AB	-2.87%	1.46B
JINYU BIO-TECHNOLOGY CO., LTD.	-15.41%	1.38B
VETOQUINOL SA	-4.30%	1.26B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-27.74%	1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD	-13.54%	1.14B
SWEDENCARE AB	-10.35%	835M

Veterinary Drugs